{"url_path":"/sec/ird/8-k/2026-09-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1228627/0001140361-26-036277-index.html","accession_number":"0001140361-26-036277","cik":"0001228627","ticker":"IRD","issuer_name":"Opus Genetics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1228627/0001140361-26-036277-index.html","primary_entity_key":"0001228627","primary_entity_name":"Opus Genetics, Inc."},"word_count":88,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n \n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n \n\n[Data presentation issued by Opus Genetics, Inc. on\nSeptember 11, 2026, furnished herewith](ef20081922_ex99-1.htm)\n\n104\n\n \n\nCover page from this Current Report on Form 8-K, formatted in Inline XBRL\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the\nundersigned hereunto duly authorized.\n\n \n\n \n\n \n\nOPUS GENETICS, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nSeptember 11, 2026\n\nBy:\n\n/s/ Dr. George Magrath\n\n \n\n \n\n \n\nDr. George Magrath\n\n \n\n \n\n \n\nChief Executive Officer"}